IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut
Citations Over TimeTop 10% of 2018 papers
Abstract
Candida albicans is implicated in intestinal diseases. Identifying host signatures that discriminate between the pathogenic versus commensal nature of this human commensal is clinically relevant. In the present study, we identify IL-9 and mast cells (MCs) as key players of Candida commensalism and pathogenicity. By inducing TGF-β in stromal MCs, IL-9 pivotally contributes to mucosal immune tolerance via the indoleamine 2,3-dioxygenase enzyme. However, Candida-driven IL-9 and mucosal MCs also contribute to barrier function loss, dissemination, and inflammation in experimental leaky gut models and are upregulated in patients with celiac disease. Inflammatory dysbiosis occurs with IL-9 and MC deficiency, indicating that the activity of IL-9 and MCs may go beyond host immunity to include regulation of the microbiota. Thus, the output of the IL-9/MC axis is highly contextual during Candida colonization and reveals how host immunity and the microbiota finely tune Candida behavior in the gut.
Related Papers
- → Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients(2018)359 cited
- → Quercetin improves gut dysbiosis in antibiotic-treated mice(2020)121 cited
- → Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile(2021)86 cited
- → Gut dysbiosis correction contributes to the hepatoprotective effects ofThymus quinquecostatusCelak extract against alcohol through the gut–liver axis(2021)20 cited
- → Gut microbiota dysbiosis in rats with LPS-induced liver diseases affected by Aronia melanocarpa polyphenols(2023)1 cited